(Q28255650)

1

0 references

Aysegul Uner

2

0 references

Nilufer Guler

3

0 references

Shuang-Yin Han

4

0 references

Dimitrios Iliopoulos

5

0 references

Peter McCue

7

0 references

Kay Huebner

ATR Regulates Fragile Site Stability

8

0 references

language of work or name

English

0 references

publication date

15 April 2004

0 references

published in

Cancer

0 references

volume

100

0 references

page(s)

1605-14

0 references

issue

8

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20137

7 January 2021

FRA3B and other common fragile sites: the weakest links

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20137

7 January 2021

Genetic alterations in cancer as a result of breakage at fragile sites

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20137

7 January 2021

The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20137

7 January 2021

Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20137

7 January 2021

Clonal genetic alterations in the lungs of current and former smokers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20137

7 January 2021

Molecular damage in the bronchial epithelium of current and former smokers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20137

7 January 2021

The tumor spectrum in FHIT-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20137

7 January 2021

The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20137

7 January 2021

Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20137

7 January 2021

Loss of heterozygosity on chromosome arm 16q in breast cancer metastases.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20137

7 January 2021

Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20137

7 January 2021

Allelic imbalance analysis of chromosome 16q shows that grade I and grade III invasive ductal breast cancers follow different genetic pathways

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20137

7 January 2021

Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20137

7 January 2021

WWOX: a candidate tumor suppressor gene involved in multiple tumor types

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20137

7 January 2021

The common fragile site FRA16D and its associated gene WWOX are highly conserved in the mouse at Fra8E1

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20137

7 January 2021

Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20137

7 January 2021

Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20137

7 January 2021

Do young breast cancer patients have worse outcomes?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20137

7 January 2021